Navigation Links
Two Week Wait Rule Not Working With Breast Cancer Patients

At the end of the last century death rates from breast cancer in the UK were among the highest in Europe. Long waiting lists, resulting in delayed diagnosis and treatment, were thought to be partly responsible.The two week wait rule is failing breast cancer patients and needs to be reviewed urgently .

In 1998 the Department of Health brought in the 2 week wait rule which stipulated that by April 1999 all patients with suspected breast cancer should be seen by a specialist within two weeks of referral by a GP.

Many studies have questioned the validity of the 2 week wait rule, but this is the first to assess the long term impact. Dr Shelley Potter and her colleagues gathered data on the number, route and outcome of Primary Care referrals to the Frenchay Brest Care Centre in Bristol between 1999 and 2005.

There were 24,999 referrals to the centre during this period, with GPs classifying each patient as being either urgent according to 2 week wait criteria or routine. Between 1999 and 2005 the number of annual referrals to the centre increased by 9%.

Routine referrals decreased by 24% but 2-week wait referrals increased by 42%. Despite the changes in referral patterns the total number of cancers remained constant over the 7 year period.

Yet the researchers found the percentage of patients diagnosed with cancer in the 2-week wait group decreased from 12.8% to 7.7% whilst the number of cancers detected in the routine group increased from 2.5% to 5.3% over the same time period.

In 2005 more than 1 in 4 (27%) patients ultimately diagnosed with cancer in 2005 was referred non-urgently. Dr Potter describes the increase in cancers diagnosed from the routine population as alarming and says:

These patients are also potentially being disadvantaged by longer clinic waits and delays in diagnosis as waiting times for routine referrals have increased in the face of increasing service demands fr
'"/>




Page: 1 2

Related medicine news :

1. Working in shifts may cause damage to your health
2. Junior Doctors Working Long Hours May Perform Poorly
3. New UK Policy Threatens The Flexible Working Scheme
4. Medicare Drug Plan Is Not Working in The US
5. Warning! Working For Long Hours On Your Computer Can Be Lethal
6. Stressed Pregnant Working Mothers Put Their Unborn Child’s Life in Dange
7. Working of Drug Department on Hold Without Drug Analyst
8. Doctor Faces Disbarment For Working In Multiple Hospitals
9. Computational Model Reveals Working of AZT in Body
10. Scientists Working On Drug Trial Guidelines
11. Scientists Uncover Complex Workings of Sperm
Post Your Comments:
Other Medicine News:Health News:Eagle Ventures' Subsidiary Hydrate2O Receives '2008 Top Gear of the Year' Award From ShapeYou.com 2Health News:Eagle Ventures' Subsidiary Hydrate2O Receives '2008 Top Gear of the Year' Award From ShapeYou.com 3Health News:Eagle Ventures' Subsidiary Hydrate2O Receives '2008 Top Gear of the Year' Award From ShapeYou.com 4Health News:Encision Reports First Fiscal Quarter Results 2Health News:Encision Reports First Fiscal Quarter Results 3Health News:Encision Reports First Fiscal Quarter Results 4Health News:Nutraceutical Reports Q3 Results 2Health News:Nutraceutical Reports Q3 Results 3Health News:Nutraceutical Reports Q3 Results 4Health News:Nutraceutical Reports Q3 Results 5Health News:Nutraceutical Reports Q3 Results 6Health News:Cardiva Medical Announces Presentation at BMO Capital Markets 2008 Focus on Healthcare Conference 2Health News:Fish Oil Fueling Equine Olympians 2Health News:Fish Oil Fueling Equine Olympians 3Health News:Healthcare Leaders Focus on Patient-Centered Care at Annual Planetree Conference 2Health News:Healthcare Leaders Focus on Patient-Centered Care at Annual Planetree Conference 3
Breaking Medicine Technology:PRA International Hosts an Infectious Diseases Audio Conference 2PRA International Hosts an Infectious Diseases Audio Conference 3Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3FDA Launches Orphan Drug Workshop at KGI 2Elsevier partners with the Royal Colleges of Surgeons of Edinburgh and Ireland 51626 1Elsevier partners with the Royal Colleges of Surgeons of Edinburgh and Ireland 51626 2New Survey Highlights Emotional Financial Toll Multi Generational Tobacco Use Takes on Parents Sandwiched In Between 51622 1New Survey Highlights Emotional Financial Toll Multi Generational Tobacco Use Takes on Parents Sandwiched In Between 51622 2New Survey Highlights Emotional Financial Toll Multi Generational Tobacco Use Takes on Parents Sandwiched In Between 51622 3New Survey Highlights Emotional Financial Toll Multi Generational Tobacco Use Takes on Parents Sandwiched In Between 51622 4Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 1Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 2Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 3Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 4Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 5Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 6Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 7